IR Calendar :: Cabaletta Bio, Inc. (CABA)

Contact

Our RESET^TM clinical trials with CABA-201 (investigational CD19-CAR T cell therapy) in lupus, myositis, systemic sclerosis, myasthenia gravis, and pemphigus vulgaris are now recruiting.

Upcoming Events

Jun 9, 2025 9:00 am EDT

2025 Annual Meeting of Stockholders

Webcast

Past Events

Mar 3, 2025 11:50 am EDT

TD Cowen 45th Annual Health Care Conference

Webcast

Feb 22, 2025 10:15 am EDT – 10:30 am EDT

5th International Conference on Lymphocyte Engineering

Webcast

Feb 15, 2025 10:00 am EDT – 11:00 am EDT

2025 American Association for the Advancement of Science Annual Meeting

Webcast

Feb 5, 2025 10:30 am EDT

Guggenheim’s SMID Cap Biotech Conference

Webcast

Dec 4, 2024 7:55 am EDT

7th Annual Evercore HealthCONx Conference

Webcast

Nov 20, 2024 11:30 am BST

Jefferies London Healthcare Conference

Webcast

Nov 18, 2024 8:00 am EDT

CABA-201 Clinical Data from RESET-Myositis™, RESET-SLE™ and RESET-SSc™ Trials Presented at ACR Convergence 2024 Investor Call

Webcast

Nov 14 – Nov 19, 2024

American College of Rheumatology (ACR) Convergence 2024

View All Past Events